AllergyEasy Urges Early Intervention Through Kid-safe Allergy Drops to Limit Asthma – PRUnderground

Posted: March 11, 2021 at 12:13 pm

While the wait and see approach may work for some aspects of kids health, research is showing that it is not helpful for pediatric allergies, which can progress from eczema to other complications like asthma without early intervention. AllergyEasy is helping to stop this progression with a child-friendly alternative to allergy shots.

AllergyEasy provides family doctors and pediatricians with a turnkey allergy treatment program. This allows the doctors to prescribe sublingual immunotherapy (SLIT), which is a needle-free, hassle-free alternative to allergy shots. Like allergy shots, SLIT desensitizes the body to allergens in the environment so that it can tolerate them without overreacting. But instead of antigen being injected into the skin, it is dispensed as under-the-tongue drops. And because it is safer than shots, it can be taken at home rather than at the doctors office.

SLIT is particularly important for young children, who may not be eligible for allergy shots because of safety concerns. However, research on a phenomenon known as the allergic march shows that if kids allergies continue untreated, they could face worsening allergic rhinitis and asthma as they grow.

Studies on the allergic march are making clear that its not just nice to intervene early but that its essential in preventing allergy-related surgeries and illnesses and chronic allergic diseases later in life, said Stuart Agren, M.D., Founder and President of AllergyEasy.

The term allergic march or atopic march is used to describe the progression of atopic disorders, such as eczema in babies to allergic rhinitis and asthma in children, teens and adults.

Agren cited early studies on this topic, including the PAT Study, which was published in the Journal of Allergy and Clinical Immunology in 2002. It showed that pollen immunotherapy reduces the development of asthma in children with seasonal allergies. A 10-year follow-up showed long-term clinical effects with significant improvement persisting seven years after children stopped their immunotherapy treatment.

Another study published in the World Allergy Organization Journal in 2008 centered specifically on sublingual immunotherapy, predicting that this new promising treatment will modify the severity of atopic eczema in infants and young children and will decrease the risk for the eventual development of asthma and thus prevent the consequences of the allergic march.

Allergy drops have been shown to be safe for children under age 5, allowing doctors to intervene early for children who suffer from allergies from young ages. Shots, on the other hand, arent usually prescribed until children are at least 7 years old due to safety concerns.

Doctors in 32 states prescribe AllergyEasys sublingual immunotherapy allergy drops. Unlike many allergy shot programs, the drops contain a comprehensive mix of allergens, including dust, mold, pet dander and the countrys most prevalent pollens. This ensures thorough coverage against the full range of allergy triggers, not just a few local pollens.

AllergyEasy drops are available to patients of all ages with a prescription from a physician. To learn more about AllergyEasy and how the pediatricians who prescribe it are helping to halt the allergic march, visit http://www.AllergyEasy.com or call (877) 276-3393.

About AllergyEasy

AllergyEasy helps allergy doctors around the country provide sublingual immunotherapy (allergy drops) to their patients who suffer with allergies to pollen and food allergies (including dairy allergy, wheat allergy, nut allergy, fruit allergy and more.) AllergyEasy can connect patients to a doctor in their area who offers sublingual allergy treatment.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The information on this website or in emails is designed for educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health problems or illnesses without consulting your physician. The news site hosting this press release is not associated with AllergyEasy or Dr. Stuart Agren. It is merely re-publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

The rest is here:
AllergyEasy Urges Early Intervention Through Kid-safe Allergy Drops to Limit Asthma - PRUnderground

Related Posts